Theratechnologies (THTX) Issues Update on Preclinical Oncology Research Program
Go back to Theratechnologies (THTX) Issues Update on Preclinical Oncology Research Program| Blyth, Inc. (NASDAQ: TH) | Delayed: 14.34 +0.55 (3.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.79 | 52 Week High | $1.54 | |||
| Open | $13.79 | 52 Week Low | $0.38 | |||
| Day High | $14.37 | P/E | 51.21 | |||
| Day Low | $13.60 | EPS | $0.28 | |||
| Volume | 598,268 | |||||
| (NASDAQ: THTX) | Delayed: 3.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.39 | 52 Week High | $ | |||
| Open | $3.39 | 52 Week Low | $ | |||
| Day High | $3.39 | P/E | N/A | |||
| Day Low | $3.39 | EPS | $ | |||
| Volume | 418,765 | |||||



